Tetanus cost-effectiveness of therapy

Tetanus Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Tetanus from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Xray
CT scan
MRI
Ultrasound
Other Imaging Studies
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Tetanus cost-effectiveness of therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Tetanus cost-effectiveness of therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Tetanus cost-effectiveness of therapy
CDC on Tetanus cost-effectiveness of therapy
Tetanus cost-effectiveness of therapy in the news
Blogs on Tetanus cost-effectiveness of therapy
Directions to Hospitals Treating Tetanus
Risk calculators and risk factors for Tetanus cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Michael Maddaleni, B.S.

Overview

The major cost encountered with tetanus is in the form of the vaccine. There are many different trade names associated with the tetanus vaccine that come with slightly different costs. The prices of the vaccines are all listed in the following tables. The tables are separated based upon pediatric doses versus adult doses. The DTaP vaccine that is mentioned in the passage stands for Diptheria, Tetanus, and Pertussis.

Cost-Effectiveness of Therapy

Pediatric vaccine

Adult vaccine